Comorbid Medical Conditions as Predictors of Overall Survival in Glioblastoma Patients
- PMID: 31882968
- PMCID: PMC6934684
- DOI: 10.1038/s41598-019-56574-w
Comorbid Medical Conditions as Predictors of Overall Survival in Glioblastoma Patients
Abstract
Glioblastoma (GBM) is an aggressive central nervous system tumor with a poor prognosis. This study was conducted to determine any comorbid medical conditions that are associated with survival in GBM. Data were collected from medical records of all patients who presented to VCU Medical Center with GBM between January 2005 and February 2015. Patients who underwent surgery/biopsy were considered for inclusion. Cox proportional hazards regression modeling was performed to assess the relationship between survival and sex, race, and comorbid medical conditions. 163 patients met inclusion criteria. Comorbidities associated with survival on individual-characteristic analysis included: history of asthma (Hazard Ratio [HR]: 2.63; 95% Confidence Interval [CI]: 1.24-5.58; p = 0.01), hypercholesterolemia (HR: 1.95; 95% CI: 1.09-3.50; p = 0.02), and incontinence (HR: 2.29; 95% CI: 0.95-5.57; p = 0.07). History of asthma (HR: 2.22; 95% CI: 1.02-4.83; p = 0.04) and hypercholesterolemia (HR: 1.99; 95% CI: 1.11-3.56; p = 0.02) were associated with shorter survival on multivariable analysis. Surgical patients with GBM who had a prior history of asthma or hypercholesterolemia had significantly higher relative risk for mortality on individual-characteristic and multivariable analyses.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Survival of glioblastoma treated with a moderately escalated radiation dose-Results of a retrospective analysis.PLoS One. 2020 May 15;15(5):e0233188. doi: 10.1371/journal.pone.0233188. eCollection 2020. PLoS One. 2020. PMID: 32413077 Free PMC article.
-
Impact of removed tumor volume and location on patient outcome in glioblastoma.J Neurooncol. 2017 Oct;135(1):161-171. doi: 10.1007/s11060-017-2562-1. Epub 2017 Jul 6. J Neurooncol. 2017. PMID: 28685405
-
Treatment and survival of patients harboring histological variants of glioblastoma.J Clin Neurosci. 2014 Oct;21(10):1709-13. doi: 10.1016/j.jocn.2014.05.003. Epub 2014 Jun 26. J Clin Neurosci. 2014. PMID: 24980627
-
Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.Eur Radiol. 2017 Mar;27(3):1096-1104. doi: 10.1007/s00330-016-4453-9. Epub 2016 Jun 21. Eur Radiol. 2017. PMID: 27329522
-
The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis.Drug Des Devel Ther. 2015 Jun 29;9:3341-8. doi: 10.2147/DDDT.S85943. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26170620 Free PMC article. Review.
Cited by
-
Thymoquinone induces apoptosis in temozolomide-resistant glioblastoma cells via the p38 mitogen-activated protein kinase signaling pathway.Environ Toxicol. 2023 Jan;38(1):90-100. doi: 10.1002/tox.23664. Epub 2022 Sep 29. Environ Toxicol. 2023. PMID: 36176197 Free PMC article.
-
Age-stratified comorbid and pharmacologic analysis of patients with glioblastoma.Brain Behav Immun Health. 2024 Mar 15;38:100753. doi: 10.1016/j.bbih.2024.100753. eCollection 2024 Jul. Brain Behav Immun Health. 2024. PMID: 38600951 Free PMC article.
-
Glioblastoma and Internal Carotid Artery Calcium Score: A Possible Novel Prognostic Partnership?J Clin Med. 2024 Mar 6;13(5):1512. doi: 10.3390/jcm13051512. J Clin Med. 2024. PMID: 38592330 Free PMC article.
-
Sex Difference in Disease-Related Adverse Events Post-Diagnosis of Lung Cancer Brain Metastases in Medicare Individuals ≥ 66 Years of Age.Cancers (Basel). 2024 Aug 28;16(17):2986. doi: 10.3390/cancers16172986. Cancers (Basel). 2024. PMID: 39272844 Free PMC article.
-
GDNF/GFRA1 signaling contributes to chemo- and radioresistance in glioblastoma.Sci Rep. 2024 Jul 31;14(1):17639. doi: 10.1038/s41598-024-68626-x. Sci Rep. 2024. PMID: 39085346 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous